The potential advance was made via a little-known pyrimidoindole molecule called UM171. Tested by the team of University of Montreal investigator Guy Sauvageau, UM171 may dramatically reduce blood stem cell transplant complications, and considerably increase patient access to the procedure.
http://ift.tt/10g3MJZ
http://ift.tt/10g3MJZ
No comments:
Post a Comment